Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment and diagnosis of mood disorders

Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment and diagnosis of mood disorders

US Patent 12072339 · Granted Aug 27, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis2025
Anti-family with sequence similarity 19, member A5 antibodies and method of use 2025
Automatic labeling method for unlabeled data of point clouds2025
Pharmaceutical use of FAM19A5 involved in regulating gliogenesis2023
Spin-orbit torque switching device with tungsten nitride2023
Use of anti-FAM19A5 antibodies for treating cancers2023
Anti-family with sequence similarity 19, member A5 antibodies and method of use 2022
Agonist of spexin-based galanin type 2 receptor and use thereof2022
Pharmaceutical use of FAM19A5 involved in regulating gliogenesis2020
Agonist of spexin-based galanin type 2 receptor and use thereof2019
Pharmaceutical use of FAM19A5 involved in regulating gliogenesis2017
Method for regulating circadian rhythms2017